
14:10 ET SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Regulus Therapeutics Inc. - RGLS

I'm PortAI, I can summarize articles.
Monteverde & Associates PC is investigating the proposed merger of Regulus Therapeutics Inc. (NASDAQ: RGLS) with Novartis AG. The merger includes an initial payment of $7.00 per share and a potential additional $7.00 per share contingent on regulatory approval. The firm, recognized for recovering millions for shareholders, offers free consultations for those concerned about their investments in Regulus.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

